Tacrolimus (FK506) P-III, Open-Label Study in Severe Refractory Ulcerative Colitis Patients or Patients Who Attended and Received Placebo in F506-CL-1107 Study.
Phase of Trial: Phase III
Latest Information Update: 21 Oct 2014
At a glance
- Drugs Tacrolimus (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 07 Oct 2009 New trial record.